SkinBioTherapeutics Plc (LON:SBTX) CEO Dr. Cath O’Neill talks to DirectorsTalk about the positive results skinbiotix shows in cream formulation. Cath explains the results, the significance, how the technology works, stability
Positive Cream Formulation Results for SkinBiotix SkinBioTherapeutics announced that the ‘cream’ formulation of its SkinBiotix® technology has passed effectiveness studies conducted on models of skin. The cream formulation will now
Dr Catherine O’Neill, CEO of SkinBioTherapeutics, commented: “The incorporation of our SkInBiotix(R) technology into an effective cream formulation is a major milestone in the development of products for the cosmetic
An interview with Cath O’Neill by Kristin Neumann, MyMicrobiome Cath is coming from the skin research area, being an expert on skin health. During the last years her research focussed on
Skinbiotherapeutics’ Dr Cath O’Neill discusses the signing of an MTA with a global consumer goods company in this exclusive interview with DirectorsTalk
Dr Cath O’Neill, CEO of SkinBioTherapeutics, commented: “Whilst these are early discussions, we are encouraged that a company of this calibre wants to look at our technology more closely through an
The microbiome is the genetic material of all the microbes – bacteria, fungi, protozoa and viruses – that live on and inside the human body. The microbiome has essential beneficial
Lathering your skin with the same stuff you put on top of your breakfast might not seem like the way to get glowing skin but some are hailing it as
Skinbiotherapeutics’ Dr Cath O’Neill discusses how they have progressed since FY results, how their SkinBiotix technology works, the significance of the scale-up and the formulations, the next key milestones and the progress for possible commercial partners in this exclusive interview with DirectorsTalk
SkinBioTherapeutics Plc (LON:SBTX) CEO Dr. Cath O’Neill talks to DirectorsTalk about the progress made since FY results in October 17. Cath provides us with an update, reminds us what SkinBioTherapeutics
© 2023 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
